
CONMED Corporation (CNMD)
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn more- Previous Close
32.76 - Open
33.31 - Bid 31.45 x 40000
- Ask 34.97 x 40000
- Day's Range
32.98 - 34.08 - 52 Week Range
31.44 - 56.64 - Volume
360,160 - Avg. Volume
496,801 - Market Cap (intraday)
1.019B - Beta (5Y Monthly) 0.93
- PE Ratio (TTM)
19.11 - EPS (TTM)
1.77 - Earnings Date Jul 29, 2026
- Forward Dividend & Yield 0.80 (2.36%)
- Ex-Dividend Date Sep 15, 2025
- 1y Target Est
39.60
Recent News
View MorePerformance Overview
Trailing total returns as of 7/2/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
-
Market Cap
986.38M
-
Enterprise Value
1.81B
-
Trailing P/E
18.51
-
Forward P/E
--
-
PEG Ratio (5yr expected)
--
-
Price/Sales (ttm)
0.74
-
Price/Book (mrq)
0.97
-
Enterprise Value/Revenue
1.32
-
Enterprise Value/EBITDA
9.72
Financial Highlights
Profitability and Income Statement
-
Profit Margin
4.00%
-
Return on Assets (ttm)
3.76%
-
Return on Equity (ttm)
5.50%
-
Revenue (ttm)
1.37B
-
Net Income Avi to Common (ttm)
54.85M
-
Diluted EPS (ttm)
1.77
Balance Sheet and Cash Flow
-
Total Cash (mrq)
35.03M
-
Total Debt/Equity (mrq)
84.59%
-
Levered Free Cash Flow (ttm)
127.06M
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Company Insights
Fair Value
Dividend Score
Hiring Score
Insider Sentiment Score
Research Reports
View More-
CONMED CORP has an Investment Rating of HOLD; a target price of $31.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Low.
CONMED CORP has an Investment Rating of HOLD; a target price of $31.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingPrice Target -
CONMED CORP has an Investment Rating of HOLD; a target price of $32.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Low.
CONMED CORP has an Investment Rating of HOLD; a target price of $32.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingPrice Target -
CONMED CORP has an Investment Rating of HOLD; a target price of $33.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Low.
CONMED CORP has an Investment Rating of HOLD; a target price of $33.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingPrice Target -
CONMED CORP has an Investment Rating of HOLD; a target price of $35.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Low.
CONMED CORP has an Investment Rating of HOLD; a target price of $35.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingPrice Target




![[Latest] Global Gastrointestinal Endoscopy Devices Market Size/Share Worth USD 19.6 Billion by 2035 at a 5.4% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)](https://s.yimg.com/uu/api/res/1.2/JDc8Q43tjkZAOscxTVa7kA--~B/Zmk9c3RyaW07aD02Mzt3PTg0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/0bec09301614ea6a3ee415db83086891.cf.webp)


